Institute of Biomedicine/Anatomy, University of Helsinki, Biomedicum, Helsinki, Finland.
Respir Res. 2011 Jan 4;12(1):2. doi: 10.1186/1465-9921-12-2.
Asthma leads to structural changes in the airways, including the modification of extracellular matrix proteins such as tenascin-C. The role of tenascin-C is unclear, but it might act as an early initiator of airway wall remodelling, as its expression is increased in the mouse and human airways during allergic inflammation. In this study, we examined whether Th1 or Th2 cells are important regulators of tenascin-C in experimental allergic asthma utilizing mice with impaired Th1 (STAT4-/-) or Th2 (STAT6-/-) immunity.
Balb/c wildtype (WT), STAT4-/- and STAT6-/- mice were sensitized with intraperitoneally injected ovalbumin (OVA) followed by OVA or PBS airway challenge. Airway hyperreactivity (AHR) was measured and samples were collected. Real time PCR and immunohistochemistry were used to study cytokines and differences in the expression of tenascin-C. Tenascin-C expression was measured in human fibroblasts after treatment with TNF-α and IFN-γ in vitro.
OVA-challenged WT mice showed allergic inflammation and AHR in the airways along with increased expression of TNF-α, IFN-γ, IL-4 and tenascin-C in the lungs. OVA-challenged STAT4-/- mice exhibited elevated AHR and pulmonary eosinophilia. The mRNA expression of TNF-α and IFN-γ was low, but the expression of IL-4 was significantly elevated in these mice. OVA-challenged STAT6-/- mice had neither AHR nor pulmonary eosinophilia, but had increased expression of mRNA for TNF-α, IFN-γ and IL-4. The expression of tenascin-C in the lungs of OVA-challenged STAT4-/- mice was weaker than in those of OVA-challenged WT and STAT6-/- mice suggesting that TNF-α and IFN-γ may regulate tenascin-C expression in vivo. The stimulation of human fibroblasts with TNF-α and IFN-γ induced the expression of tenascin-C confirming our in vivo findings.
Expression of tenascin-C is significantly attenuated in the airways of STAT4-/- mice, which may be due to the impaired secretion of TNF-α and IFN-γ in these mice.
哮喘会导致气道结构发生变化,包括细胞外基质蛋白(如 tenascin-C)的改变。tenascin-C 的作用尚不清楚,但它可能作为气道壁重塑的早期启动子,因为在过敏炎症期间,其在小鼠和人类气道中的表达增加。在这项研究中,我们利用 Th1 (STAT4-/-)或 Th2 (STAT6-/-)免疫功能受损的小鼠,研究了 Th1 或 Th2 细胞是否是实验性变应性哮喘中 tenascin-C 的重要调节因子。
Balb/c 野生型(WT)、STAT4-/-和 STAT6-/-小鼠经腹腔注射卵清蛋白(OVA)致敏后,用 OVA 或 PBS 气道攻击。测量气道高反应性(AHR)并收集样本。实时 PCR 和免疫组织化学用于研究细胞因子和 tenascin-C 表达的差异。体外用 TNF-α和 IFN-γ处理人成纤维细胞后,测量 tenascin-C 的表达。
OVA 攻击的 WT 小鼠表现出气道过敏炎症和 AHR,同时肺中 TNF-α、IFN-γ、IL-4 和 tenascin-C 的表达增加。OVA 攻击的 STAT4-/-小鼠表现出气道高反应性和肺嗜酸性粒细胞增多。这些小鼠 TNF-α和 IFN-γ的 mRNA 表达水平较低,但 IL-4 的表达显著升高。OVA 攻击的 STAT6-/-小鼠既没有气道高反应性也没有肺嗜酸性粒细胞增多,但 TNF-α、IFN-γ和 IL-4 的 mRNA 表达增加。OVA 攻击的 STAT4-/-小鼠肺中 tenascin-C 的表达弱于 OVA 攻击的 WT 和 STAT6-/-小鼠,提示 TNF-α和 IFN-γ可能在体内调节 tenascin-C 的表达。TNF-α和 IFN-γ刺激人成纤维细胞诱导 tenascin-C 的表达,证实了我们的体内发现。
STAT4-/- 小鼠气道中 tenascin-C 的表达显著减弱,这可能是由于这些小鼠中 TNF-α和 IFN-γ分泌受损所致。